Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$525.19 USD
+16.22 (3.19%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $525.58 +0.39 (0.07%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Elevance Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 5,991.00 | 6,019.00 | 6,095.00 | 4,572.00 | 4,807.00 |
Depreciation/Amortization & Depletion | 1,745.00 | 1,675.00 | 1,302.00 | 1,154.00 | 1,133.00 |
Net Change from Assets/Liabilities | -535.00 | 253.00 | 1,193.00 | 5,203.00 | -192.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 860.00 | 452.00 | -226.00 | -241.00 | 313.00 |
Net Cash From Operating Activities | 8,061.00 | 8,399.00 | 8,364.00 | 10,688.00 | 6,061.00 |
Property & Equipment | -1,296.00 | -1,152.00 | -1,087.00 | -1,021.00 | -1,077.00 |
Acquisition/ Disposition of Subsidiaries | -1,552.00 | -649.00 | -3,476.00 | -1,976.00 | 0.00 |
Investments | -2,622.00 | -2,639.00 | -5,012.00 | -4,282.00 | -1,665.00 |
Other Investing Activities | -102.00 | -120.00 | -63.00 | -45.00 | -50.00 |
Net Cash from Investing Activities | -5,572.00 | -4,560.00 | -9,638.00 | -7,324.00 | -2,792.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2,524.00 | -2,134.00 | -1,697.00 | -2,524.00 | -1,514.00 |
Issuance (Repayment) of Debt | 665.00 | 872.00 | 1,394.00 | 402.00 | 1,053.00 |
Increase (Decrease) Short-Term Debt | -3.00 | 1,225.00 | 2,281.00 | 149.00 | -868.00 |
Payment of Dividends & Other Distributions | -1,395.00 | -1,229.00 | -1,104.00 | -954.00 | -818.00 |
Other Financing Activities | -92.00 | -52.00 | -451.00 | 360.00 | -119.00 |
Net Cash from Financing Activities | -3,349.00 | -1,318.00 | 423.00 | -2,567.00 | -2,266.00 |
Effect of Exchange Rate Changes | -1.00 | -14.00 | -10.00 | 7.00 | 0.00 |
Net Change In Cash & Equivalents | -861.00 | 2,507.00 | -861.00 | 804.00 | 1,003.00 |
Cash at Beginning of Period | 7,387.00 | 4,880.00 | 5,741.00 | 4,937.00 | 3,934.00 |
Cash at End of Period | 6,526.00 | 7,387.00 | 4,880.00 | 5,741.00 | 4,937.00 |
Diluted Net EPS | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 |
Fiscal Year End for Elevance Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 5,991.00 | 5,160.00 | 3,860.00 | 2,004.00 |
Depreciation/Amortization & Depletion | NA | 1,745.00 | 1,321.00 | 895.00 | 462.00 |
Net Change from Assets/Liabilities | NA | -535.00 | 3,821.00 | 3,611.00 | 4,054.00 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 860.00 | 730.00 | 53.00 | -51.00 |
Net Cash From Operating Activities | NA | 8,061.00 | 11,032.00 | 8,419.00 | 6,469.00 |
Property & Equipment | NA | -1,296.00 | -970.00 | -651.00 | -301.00 |
Acquisition/ Disposition of Subsidiaries | NA | -1,552.00 | 12,961.00 | -1,651.00 | -1,638.00 |
Investments | NA | -2,622.00 | -16,452.00 | -1,508.00 | -1,217.00 |
Other Investing Activities | NA | -102.00 | -82.00 | -46.00 | -28.00 |
Net Cash from Investing Activities | NA | -5,572.00 | -4,543.00 | -3,856.00 | -3,184.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -2,524.00 | -1,636.00 | -1,187.00 | -579.00 |
Issuance (Repayment) of Debt | NA | 665.00 | 666.00 | 756.00 | 991.00 |
Increase (Decrease) Short-Term Debt | NA | -3.00 | -842.00 | -735.00 | -496.00 |
Payment of Dividends & Other Distributions | NA | -1,395.00 | -1,049.00 | -701.00 | -351.00 |
Other Financing Activities | NA | -92.00 | -94.00 | -94.00 | -96.00 |
Net Cash from Financing Activities | NA | -3,349.00 | -2,955.00 | -1,961.00 | -531.00 |
Effect of Exchange Rate Changes | NA | -1.00 | -2.00 | 2.00 | 1.00 |
Net Change In Cash & Equivalents | NA | -861.00 | 3,532.00 | 2,604.00 | 2,755.00 |
Cash at Beginning of Period | NA | 7,387.00 | 7,387.00 | 7,387.00 | 7,387.00 |
Cash at End of Period | NA | 6,526.00 | 10,919.00 | 9,991.00 | 10,142.00 |
Diluted Net EPS | NA | 3.68 | 5.45 | 7.79 | 8.30 |